Works by Takano, Hirokuni


Results: 24
    1
    2
    3
    4
    5
    6

    Bevacizumab combined with platinum-taxane chemotherapy as first-line treatment for advanced ovarian cancer: a prospective observational study of safety and efficacy in Japanese patients (JGOG3022 trial).

    Published in:
    International Journal of Clinical Oncology, 2019, v. 24, n. 1, p. 103, doi. 10.1007/s10147-018-1319-y
    By:
    • Komiyama, Shinichi;
    • Kato, Kazuyoshi;
    • Inokuchi, Yuki;
    • Takano, Hirokuni;
    • Matsumoto, Takashi;
    • Hongo, Atsushi;
    • Asai-Sato, Mikiko;
    • Arakawa, Atsushi;
    • Kamiura, Shoji;
    • Tabata, Tsutomu;
    • Takeshima, Nobuhiro;
    • Sugiyama, Toru
    Publication type:
    Article
    7
    8
    9

    Genetic characteristics of platinum-sensitive ovarian clear cell carcinoma.

    Published in:
    Japanese Journal of Clinical Oncology, 2023, v. 53, n. 9, p. 781, doi. 10.1093/jjco/hyad045
    By:
    • Saito, Ryosuke;
    • Kuroda, Takafumi;
    • Yoshida, Hiroshi;
    • Sudo, Kazuki;
    • Saito, Motoaki;
    • Tanabe, Hiroshi;
    • Takano, Hirokuni;
    • Yamada, Kyosuke;
    • Kiyokawa, Takako;
    • Yonemori, Kan;
    • Kato, Tomoyasu;
    • Okamoto, Aikou;
    • Kohno, Takashi
    Publication type:
    Article
    10
    11
    12
    13

    Re-administration of platinum-based chemotherapy for recurrent endometrial cancer: an ancillary analysis of the SGSG-012/GOTIC-004/Intergroup study.

    Published in:
    International Journal of Clinical Oncology, 2024, v. 29, n. 10, p. 1594, doi. 10.1007/s10147-024-02585-1
    By:
    • Nagao, Shoji;
    • Nishio, Shin;
    • Takehara, Kazuhiro;
    • Sato, Shinya;
    • Satoh, Toyomi;
    • Shimada, Muneaki;
    • Yamaguchi, Satoshi;
    • Tanabe, Hiroshi;
    • Takano, Masashi;
    • Horie, Kouji;
    • Takei, Yuji;
    • Imai, Yuichi;
    • Hibino, Yumi;
    • Hasegawa, Kosei;
    • Takekuma, Munetaka;
    • Nakamura, Kazuto;
    • Takano, Hirokuni;
    • Fujiwara, Keiichi;
    • Masuyama, Hisashi
    Publication type:
    Article
    14
    15
    16

    Veliparib with frontline chemotherapy and as maintenance in Japanese women with ovarian cancer: a subanalysis of efficacy, safety, and antiemetic use in the phase 3 VELIA trial.

    Published in:
    International Journal of Clinical Oncology, 2023, v. 28, n. 1, p. 163, doi. 10.1007/s10147-022-02258-x
    By:
    • Mizuno, Mika;
    • Ito, Kimihiko;
    • Nakai, Hidekatsu;
    • Kato, Hidenori;
    • Kamiura, Shoji;
    • Ushijima, Kimio;
    • Nagao, Shoji;
    • Takano, Hirokuni;
    • Okadome, Masao;
    • Takekuma, Munetaka;
    • Tokunaga, Hideki;
    • Nagase, Satoru;
    • Aoki, Daisuke;
    • Coleman, Robert L.;
    • Nishimura, Yasuko;
    • Ratajczak, Christine K.;
    • Hashiba, Hideyuki;
    • Xiong, Hao;
    • Katsumata, Noriyuki;
    • Enomoto, Takayuki
    Publication type:
    Article
    17
    18
    19
    20
    21
    22
    23
    24